Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Levothyroxine recalled?

Yes — there is an active recall. 62 ongoing FDA recalls mention Levothyroxine (186 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Levothyroxine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Levothyroxine recalls on record

none so far in 2026; 186 on record, newest first
Class II · Moderate risk

Levothroid

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Terminated Stability / shelf life Lloyd Inc. of Iowa NDC 0456-1325-01 D-449-2013
Class II · Moderate risk

Levothroid

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Terminated Stability / shelf life Lloyd Inc. of Iowa NDC 0456-1331-01 D-448-2013
Class II · Moderate risk

Levothroid

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Terminated Stability / shelf life Lloyd Inc. of Iowa NDC 0456-1324-01 D-447-2013
Class II · Moderate risk

Levothroid

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Terminated Stability / shelf life Lloyd Inc. of Iowa NDC 0456-1330-01 D-446-2013
Class II · Moderate risk

Levothroid

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Terminated Stability / shelf life Lloyd Inc. of Iowa NDC 0456-1323-01 D-445-2013
Class II · Moderate risk

Levothroid

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Terminated Stability / shelf life Lloyd Inc. of Iowa NDC 0456-1329-01 D-436-2013
Class II · Moderate risk

Levothroid

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Terminated Stability / shelf life Lloyd Inc. of Iowa NDC 0456-1322-01 D-434-2013
Class II · Moderate risk

Levothroid

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Terminated Stability / shelf life Lloyd Inc. of Iowa NDC 0456-1321-01 D-432-2013
Class II · Moderate risk

Synthroid (Levothyroxine Sodium)

Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.

Terminated Labeling / mix-up Abbott Laboratories NDC 0074-7069-90 D-107-2013
Class II · Moderate risk

Levothroid

Subpotent; 9-month stability interval

Terminated Wrong potency / content Lloyd Inc. of Iowa NDC 0456-1322-01 D-103-2013
Class II · Moderate risk

Levothroid

Subpotent; 9-month stability interval

Terminated Wrong potency / content Lloyd Inc. of Iowa NDC 0456-1321-01 D-101-2013
Class II · Moderate risk

Synthroid (levothyroxine sodium)

Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.

Terminated Packaging defect Abbott Laboratories D-1696-2012